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Abstract The complications caused by overweight, obesity
and type 2 diabetes are one of the main problems that increase
morbidity and mortality in developed countries. Hypothalam-
ic metabolic sensors play an important role in the control of
feeding and energy homeostasis. PAS kinase (PASK) is a
nutrient sensor proposed as a regulator of glucose metabolism
and cellular energy. The role of PASK might be similar to
other known metabolic sensors, such as AMP-activated pro-
tein kinase (AMPK) and the mammalian target of rapamycin
(mTOR). PASK-deficient mice resist diet-induced obesity. We
have recently reported that AMPK and mTOR/S6K1 path-
ways are regulated in the ventromedial and lateral hypothala-
mus in response to nutritional states, being modulated by
anorexigenic glucagon-like peptide-1 (GLP-1)/exendin-4 in
lean and obese rats. We identified PASK in hypothalamic
areas, and its expression was regulated under fasting/re-
feeding conditions and modulated by exendin-4. Furthermore,
PASK-deficient mice have an impaired activation response of
AMPK and mTOR/S6K1 pathways. Thus, hypothalamic
AMPK and S6K1 were highly activated under fasted/re-fed
conditions. Additionally, in this study, we have observed that
the exendin-4 regulatory effect in the activity of metabolic
sensors was lost in PASK-deficient mice, and the anorexigenic
properties of exendin-4 were significantly reduced, suggesting
that PASK could be a mediator in the GLP-1 signalling
pathway. Our data indicated that the PASK function could
be critical for preserving the nutrient effect on AMPK and
mTOR/S6K1 pathways and maintain the regulatory role of
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exendin-4 in food intake. Some of the antidiabetogenic effects
of exendin-4 might be modulated through these processes.
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Introduction
The PAS kinase (PASK), also termed PASKIN, is a nutrient
sensor conserved from yeast to human beings. In mammals,
PASK is involved in the regulation of glucose and energy
metabolism homeostasis [1–3]. Thus, it has been proposed
that PASK is activated by small metabolites and may regulate
glycogen synthesis and protein translation. PASK could reg-
ulate glucose metabolism and cellular energy homeostasis
[4, 5]. Initially, PASK-deficient mice showed no developmen-
tal, growth, or reproductive defects [6]. Later investigation
indicated that PASK-deficient mice are resistant to diet-
induced obesity, and PASK knockdown by RNAi in cultured
myoblasts causes increased glucose and palmitate oxidation
and elevated cellular ATP levels [7]. Additionally, PASK is
also implicated in the regulation of glucagon secretion by
glucose, and PASK expression was lower in pancreatic islets
from human with type 2 diabetes [8]. The role of PASK might
therefore be similar to better knownmetabolic sensors, such as
AMP-activated protein kinase (AMPK) and mammalian tar-
get of rapamycin (mTOR). AMPK senses cellular energy
availability by detecting the AMP/ATP ratio. AMPK is acti-
vated in low energy states and promotes ATP-generating
catabolic pathways and inhibits anabolic reactions [9–11].
By contrast, mTOR and its downstream target, the S6 kinase
1 (S6K1), respond to nutrients and hormonal signals [12–14]
and increase their activities in the presence of nutrient abun-
dance [15]. Thus, mTOR complex 1 (mTORC1) is
rapamycin- and nutrient-sensitive, regulating metabolism
and cell growth in response to several environmental signals.
Accordingly, amino acids, growth factors and mitogens acti-
vate mTORC1 and lead to an increase in protein synthesis and
stimulation of cell growth [16]. By contrast, mTORC1 activity
is inhibited under conditions of energy depletion coordinated
with AMPK activity. An increase in the AMP/ATP ratio
activates AMPK, which phosphorylates the tuberous sclerosis
complex 2 (TSC2), and this modification induces the concom-
itant inhibition of mTORC1 mediated by TSC1-TSC2 com-
plex [17]. Furthermore, AMPK phosphorylates raptor
(rapamycin-sensitive adaptor protein of mTOR) in mTORC1,
inducing the downregulation of this complex [18]. Addition-
ally, energy depletion inhibits mTORC1 through an indepen-
dent mechanism of AMPK activation [19]. AMPK is addi-
tionally inhibited by the phosphorylation of mTOR/S6K1
[20]. The hypothalamic AMPK [21] and mTOR/S6K
pathways [22] have been implicated in the control of feeding
and the regulation of energy balances.
We have recently reported that PASK expression is regulated
by glucose and glucagon-like peptide-1 (GLP-1) in rat ventro-
medial (VMH) and lateral hypothalamus (LH) areas from hy-
pothalamic organotypic cultures and that there is an impaired
response of AMPK and mTOR/S6K1 pathways in PASK-
silenced neuroblastoma cells [23]. GLP-1 is an incretin,
resulting from the posttranslational processing of pre-
proglucagon that is secreted by L-intestinal cells after eating.
Its structural analogue, exendin-4, is used as an antidiabetogenic
agent due to its longer half-life and ability to promote the
secretion of insulin when glucose increases. In addition,
exendin-4 has anorexigenic properties administered both pe-
ripheral and at the central nervous system level [24]. In this
sense, we have recently reported that the regulation of AMPK
and mTOR/S6K1 pathways in response to changes in nutrient
concentration could be modulated by the presence of GLP-1/
exendin-4, which counteracts the activation/inactivation of
AMPK and mTOR/S6K1 in the hypothalamic areas involved
in feeding behaviour (VMH and LH) [25]. Thus, it seems that
exendin-4 might balance the proper activation of these meta-
bolic sensors in lean and obese rats, helping to improve patho-
physiological states such as obesity [25].
Here, we have investigated the expression of PASK in
mouse brain, as well as the effects of nutrients and exendin-
4 on its expression in hypothalamic areas involved in feeding
behaviour. Furthermore, we have investigated the possible
relationships between PASK and other metabolic sensors by
analysing the expression and activity of AMPK and
mTOR/S6K1 pathways in VMH and LH areas under fasting
and re-feeding conditions, as well as the effect of the anorex-
igenic peptide exendin-4 in PASK-deficient mice.
Materials and Methods
Animals
All procedures involving animals were approved by the ap-
propriate Institutional Review Committee and met the guide-
lines for the care of animals specified by the European Com-
munity. The animals usedwere 10- to 16-week-old males (25–
30 g), C57Bl/6 wild-type and PASK-deficient mice back-
crossed into C57Bl/6 for at least 12 generations [6]. The
animals were fed ad libitum with a standard pellet diet and
housed at a constant temperature (21 °C) on a 12-h light-dark
cycle, with lights on at 8 a.m.
Measuring Blood Plasma Glucose and Insulin Levels
Glucose levels were sampled from mouse tail bleeds using a
Glucometer Elite meter (Bayer Corp., Elkhart, IN, USA).
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Blood plasma insulin levels were determined using a compet-
itive ELISA Kit (Millipore, MA, USA), following the manu-
facturer’s instructions.
X-Gal Staining
Hypothalamic slices of 500μmwere used for 5-bromo-4-chloro-
3-indolyl-β-d-galactopyranoside (X-Gal) staining. Hypothalam-
ic slices were fixed in 0.2%glutaraldehyde, 5mMEGTA, 2mM
MgCl2 and 0.1 M Na-phosphate buffer (pH 7.3) for 16 h. Then,
they were permeabilized in 0.01 % Na-deoxycholate, 0.02 %
NP-40, 2 mM MgCl2 and 0.1 M Na-phosphate buffer (pH 7.3)
and incubated in X-Gal solution [5 mM K3Fe(CN)6, 5 mM
K4Fe(CN)6, 2 mM MgCl2, 0.02 % NP-40, 0.01 % Na-
deoxycholate, 0.1 M Na-phosphate buffer (pH 7.3), 0.1 % X-
Gal] for at least 5 h at 30 °C until colour developed.
Isolation of Hypothalamic Areas
Mice Pask−/− and C57Bl/6 wild-type mice were fasted for
48 h. Some animals were re-fed for 3 h, and some of them
were treated subcutaneously with exendin-4 (250 ng/100 g
body weight, Bachem) for 1 to 4 h. The hypothalami were
removed from the brains and sectioned at 500 μm. VMH and
LH were isolated by micropunching according to the stereo-
taxic coordinates [26, 27].
Polymerase Chain Reaction
The total RNA from VMH and LH from C57Bl/6 wild-type
and PASK-deficient mice was isolated by the acid-
guanidinium isothiocyanate method [28]. RNA integrity was
tested with the Bioanalyzer 2100 (Agilent), and cDNA syn-
thesis was developed using the High-Capacity cDNAArchive
Kit (Applied Biosystems), using 1 μg of RNA as a template,
following the manufacturer’s instructions. In order to ensure
the purity of VMH and LH, a PCR was developed using the
primers to amplify steroidogenic factor 1 (Sf-1) and prepro-
orexin (Online resource 1) as described [23]. Briefly, the PCR
conditions were as follows: 94 °C for 2 min, followed by 30
cycles at 94 °C for 30 s, 60 °C for 30 s and 72 °C for 1 min,
and a final extension cycle at 72 °C for 10 min. The amplified
fragments were analysed by agarose gel electrophoresis.
Real-time polymerase chain reaction (TaqMan® Assay).
The mRNA levels of Pask, Ampkα2, Glp-1r, β-actin and 18s
rRNAwere measured by real-time quantitative RT-PCR using
TaqMan® probes (Applied Biosystems) (Online resource 1)
as described [23]. Briefly, PCR was developed in a 7900HT
Fast Real-Time PCR System (Applied Biosystems). The con-
ditions were 50 °C for 2 min, 95 °C for 10min, followed by 40
cycles at 95 °C for 15 s and 60 °C for 1 min.
Multiple gene expression analyses in TaqMan® Gene Ex-
pression Assay. Quantity real-time PCR was developed using
the TaqMan® Fast Universal PCR Master Mix and Roche
Diagnostics on TaqMan® Array 96-Well Fast Plates contain-
ing 17 customized duplicated genes (Online resource 1) as
described [23]. Briefly, 2 μl of the synthesized cDNA was
diluted in a final volume of 100 μl and applied to each port of
the TLDA card. PCR was developed in a 7900HT Fast Real-
Time PCR System (Applied Biosystems). The condi-
tions were 50 °C for 2 min and 95 °C for 10 min,
followed by 40 cycles at 95 °C for 15 s and 60 °C for
1 min. 18s and β-actin housekeeping genes were used
for normalization. Median normalization was performed
as follows: the median cycle threshold (CT) value of all
the genes on each TLDA card was subtracted from the
CT value for each reaction well on that card, whereby
after normalization, the median CT value on each card
was zero. The average 18s or β-actin CT values on each
TLDA card were then subtracted from the CT value for
each reaction well on that card.
Protein Expression and Activity of AMPK and mTOR/S6K1
Pathways
For the analysis of protein expression and activity by
western blotting, a tiny piece of frozen liver (~150 mg)
or the hypothalamic nuclei were immediately lysed in
RIPA buffer [150 mM NaCl, 50 mM Tris-HCl (pH 7.2),
1 % sodium deoxycholate, 1 % Triton X-100, 0.25 mM
EDTA (pH 8.0) , 10 mM NaF, 1 mM sodium
orthovanadate, 2.5 mM sodium pyrophosphate] and a
tablet of protease inhibitor cocktail (Roche Diagnostics,
Mannheim, Germany). Tissues were then exposed im-
mediately to microwave irradiation for 5 s and then
homogenized [25]. Total and phosphorylated forms were
detected by western blotting using the antibodies de-
scribed (Table 1). The blots were reprobed for β-actin.
Finally, the blots were scanned and quantified using
Quantity One software (Bio-Rad, GS-800 Densitometer).
Food Intake
The feeding response to exendin-4 treatment was tested as
previously described [29]. Briefly, male C57Bl/6 wild-type
and PASK-deficient mice were fasted overnight. Exendin-4
(250 ng/100 g body weight, Bachem) in saline or the saline
vehicle alone was subcutaneously injected, and 1 h after the
exendin injection, the mice were re-fed and the food intake
was measured 30, 60 and 120 min later.
Statistical Analyses
All values are presented as means ± SEM. The groups were
compared using a t test. P<0.05 was considered statistically
significant.
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Results
PASK Expression in Mouse Hypothalamus
X-Gal staining of hypothalamic region of Pask−/− mice re-
vealed PASK-positive cells located in several hypothalamic
areas, mainly in arcuate and paraventricular nuclei, as well as
in VMH and less intensively in LH. A strong labelling was
also observed in the walls lining the third ventricle (Fig. 1a).
PaskmRNAwas detected using two sets of primers (Fig. 1b).
No detection of the PaskmRNA in PASK-deficient mice was
observed using primers that recognize the kinase domain, as is
to be expected in Pask−/−mice. However, primers recognizing
exons 7 and 8, which are maintained in PASK-deficient mice,
recorded a higher level of mRNA in both VMH and LH in
Pask−/−mice compared to wild-type specimens (Fig. 1b, c).
Effect of PASK Deficiency on the Expression of Metabolic
Genes in Mouse VMH and LH
To evaluate the role that PASK plays in the control of feeding,
we analysed the expression of other metabolic sensors in
hypothalamic areas involved in food intake and energy ho-
meostasis. The mRNA levels were measured with real-time
RT-PCR in VMH and LH from fasted C57Bl/6 wild-type and
PASK-knockout mice in the presence or absence of exendin-
4. We measured the expression of genes coding for metabolic
sensors including AMPKα2 and mTOR/S6K1; several genes
as direct or indirect regulators of metabolic sensor activity,
such as AKT, LKB1, PKARIIα and TSC2; several direct
substrates of PASK, AMPK and mTOR/S6K1 pathways: S6,
eIF4B, eEF-2K, eEF1-α1 and nNOS; genes whose products
regulate carbohydrate metabolism: GAPDH and PDK1; and
additionally, GLP-1 receptor (GLP-1R), homeodomain-
interacting protein kinase 2 (HIPK2), a mediator of apoptotic
pathways in neurons and a housekeeping gene: β-actin. In the
absence of any treatment, the expression of mRNA coding for
mTOR, AMPKα2 and S6K1 was similar in VMH and LH
from wild-type and PASK-deficient mice, but PASK-deficient
mice had lower Ampkα2mRNA levels in VMH, and a similar
tendency was observed in LH, although no significant differ-
ences were found (Fig. 2a). The expression of genes coding
for AKT, LKB1, PKARIIα and TSC2 was similar in PASK-
deficient and wild-type mice (Fig. 2b); our data also showed
no changes in the expression of mRNAs coding for S6,
eEF1-α1, eEF-2K, eIF4B and nNOS1 (Online resource 2A),
and similar expressions of GADPH and PDK1 (Online
resource 2B) were found in both types of mice. The expres-
sion of genes coding for PKARIIα, eIF4B, eEF1-α1 and
nNOS1 was lower in LH than VMH in wild-type mice. By
contrast, Hipk2mRNA levels were higher in LH from PASK-
deficient mice (Fig. 2c). Therefore, our data suggests that the
expression of Ampkα2 and Hipk2 (a mediator of apoptotic
pathways in neurons) might be mediated by PASK protein
either directly or indirectly. After exendin-4 treatment, we
observed a decreased expression of GLP-1R in VMH and
LH from wild-type mice (Fig. 2c). By contrast, the presence
of exendin-4 increased the expression of LKB1, eEF1-α1, and
S6 in VMH fromwild-type mice (Fig. 2b and Online resource
2A). However, the absence of an exendin-4 effect in PASK-
deficient mice explains the lower levels of LKB1, TSC2,
AKT1, mTOR, eEF1-α1 and nNOS1 in VMH from PASK-
deficient mice compared to their wild-type counterparts.
PASK Expression Responds to Fasting and Re-feeding
in VMH and LH from Wild-Type Mice
PASK has already been proposed as a nutrient sensor [7], so
we analysed PASK mRNA expression under fasting and re-
feeding conditions in VMH and LH from wild-type and
PASK-deficient mice. In order to ensure the purity of these
hypothalamic nuclei obtained by micropunching from mouse
hypothalamus, Sf-1 and prepro-orexin genes were used as
markers of these specific nuclei, respectively. The mRNA
encoding SF-1 was mostly present in VMH, whereas
prepro-orexin mRNA levels were higher in LH (Fig. 3a).
Re-feeding increased PaskmRNA expression in LH in wild-
type mice. The PaskmRNA level was lower in LH than that in
Table 1 Antibodies and condi-
tions used for western blot assays Antibody Host Manufacturer Dilution used
Anti-ACC Rabbit Millipore Iberica, Madrid, Spain 1:1,000
Anti-phospho-ACC(Ser 79) Rabbit Millipore Iberica, Madrid, Spain 1:500
Anti-AMPKα Rabbit Cell Signaling, Danvers, MA, USA 1:1,000
Anti-phospho-AMPKα(Thr172) Rabbit Cell Signaling, Danvers, MA, USA 1:1,000
Anti-β-actin Mouse Sigma-Aldrich, Saint Louis, Missouri, USA 1:5,000
Anti-S6K1 Rabbit Cell Signaling, Danvers, MA, USA 1:1,000
Anti-phospho-S6K1(Thr389) Rabbit Cell Signaling, Danvers, MA, USA 1:1,000
Anti-rabbit-HRP Goat Millipore Iberica, Madrid, Spain 1:5,000
Anti-mouse-HRP Goat Bethyl Laboratories, Montgomery, USA 1:5,000
Mol Neurobiol (2014) 50:314–326 317
VMH in wild-type mice. The truncated Pask (exon 7 and 8)
mRNA levels of PASK-deficient mice were also elevated in
both hypothalamic areas (Fig. 3b).
Impaired Activation of AMPK and Acetyl-CoA Carboxylase
in VMH and LH from PASK-Deficient Mice After Fasting
or Re-feeding States
Hypothalamic metabolic sensors, AMPK and mTOR/S6K1
pathways, play a critical role in monitoring food intake, and
we therefore checked their response to fasting/re-feeding sit-
uations in PASK-deficient mice. The activation of AMPKwas
checked using an anti-phospho-AMPKα (Thr172). The max-
imal AMPK activity was observed in the fasted state. Three
hours of re-feeding after fasting reduced AMPK activity in
VMH and LH areas by ~40 and 50 %, respectively, in wild-
type mice (Fig. 4a). In contrast, AMPK activity was elevated
in both fasted and re-fed states in hypothalamic areas in
PASK-deficient mice (Fig. 4a). Increased AMPK activ-
ity after fasting was reversed by exendin-4 administra-
tion for 1 h, specifically in LH from wild-type mice.
However, the exendin-4 effect on AMPK activity was
lost in PASK-deficient mice (Fig. 4a). AMPK activation
is associated with the enhanced phosphorylation of its
downstream target acetyl-CoA carboxylase (ACC). The
level of ACC phosphorylation in LH was also reduced
after re-feeding in wild-type mice (Fig. 4b). The
phospho-ACC levels were elevated in both fasted and
re-fed states in hypothalamic areas in PASK-deficient
mice (Fig. 4b).
Altered S6K1 Activation in VMH and LH
from PASK-Deficient Mice Under Fasting
or Re-feeding Conditions
The activation/inhibition of the mTOR/S6K1 pathway
was determined. In fasted conditions or after 3 h of re-
feeding, the amount of S6K1 was similar in VMH and
LH in both PASK-deficient and wild-type mice. The
activation of S6K1 was detected using anti-phospho-
S6K1 (Thr389). Re-feeding increased S6K1 activity sig-
nificantly in LH, and similar results were observed in
VMH, although no significant differences were recorded
(Fig. 5). However, S6K1 activity was enhanced in both
Fig. 1 PASK is expressed in VMH and LH of mice. a Pask expression
pattern, revealed by X-gal staining of a 500-μm hypothalamic slice from
Pask−/− mice. (a′) and (b′) show a higher magnification of boxed areas.
PVN paraventricular nucleus, VMH ventromedial nucleus, ARC arcuate
nucleus, 3 V third ventricle. b PaskmRNA levels in VMH and LH from
wild-type (WT) and PASK-deficient mice (Pask−/−). The mRNA coding
for PASKwas detected by quantitative real-time PCR, using two different
probes located 5′ to the targeted region or located in the targeted kinase
domain, as indicated. The bars represent the means ± SEM of the ratios
respect to β-actin of the values obtained from quantitative real-time PCR
of three independent experiments carried out in duplicate. The values
obtained in the VMH of the wild-type animals were considered as 1.
**P<0.01, WT vs. Pask−/−. c Schematic representation of the deleted
kinase domain in Pask−/− mice and the location of probes used in the
quantitative real-time PCR
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fasted and re-fed states in PASK-deficient mice (Fig. 5).
Exendin-4 regulates hypothalamic S6K1 activation
in vivo in fasted and re-fed wild-type mice. Nevertheless,
the exendin-4 effect increased S6K1 activity in fasted
Fig. 2 Effects of PASK deficiency on the expression of several genes in
VMH and LH. Quantitative real-time PCR was used to analyse the
expression of several genes as shown (Online resource 1). The mRNA
levels were quantified in VMH and LH from fasted C57Bl/6 wild-type
and PASK-knockout mice in the presence or absence of exendin-4. The
bars represent the ratios with respect to β-actinof the mRNA levels of the
different genes. The value obtained in the VMH from wild-type mice
(WT) treated with a vehicle without exendin-4 was taken as 1. Results are
means ± SEM; n=3–4 animals per condition. *P<0.05, **P<0.01,
***P<0.001, WT vs. Pask−/−; #P<0.05, ###P<0.001, vehicle vs.
exendin-4; ††P<0.01, †††P<0.001, VMH vs. LH
Fig. 3 Nutrients and exendin-4 modulate Paskgene expression in the VMH
and LH fromwild-type and PASK-deficient mice. aRT-PCR analysis of Sf-1,
prepro-orexinand β-actinmRNA expression in the VMH and LH fromwild-
type mice. bPaskmRNA and β-actin levels were quantified by real-time RT-
PCR in VMH and LH from fasted (FASTING) and re-fed (RE-FEEDING)
wild-type (WT) and PASK-deficient (Pask−/−) mice. The data were normal-
ized to fasting untreated wild-type mice. Results are means ± SEM; n=3–4
animals per condition. *P<0.05, fasted vs. re-feed; #P<0.05, ##P<0.01,
###P<0.001, WT vs. Pask−/−; †P<0.05, ††P<0.01, †††P<0.001, VMH vs.
LH; ‡P<0.05, vehicle vs. exendin-4
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conditions and, in contrast, 3 h of re-feeding significantly
decreased S6K1 activation in LH with similar results,
although no significant differences were recorded in
VMH from wild-type mice (Fig. 5). However, the
exendin-4 effect on S6K1 activity was lost in PASK-
deficient mice (Fig. 5).
Fig. 4 Impaired effect of nutrients on AMPK and ACC activity in VMH
and LH from Pask−/− mice. a Immunoblot analysis of phospho-AMPK
(Thr172) (P-AMPK) and total AMPK (AMPK). b Immunoblot analysis
of phospho-ACC (Ser-79) (P-ACC) and total ACC (ACC). The blots
were reprobed for β-actin to normalize the results. Bar graphs represent
means ± SEM of the densitometric values, β-actin and non-phosphory-
lated forms; n=3–4 animals per condition. Representative western blots
of the graphs are also shown. The values were normalized by fasted wild-
type untreated mice. *P<0.05, ***P<0.001, fasted vs. re-feed; #P<0.05,
##P<0.01, WT vs. Pask−/−; ‡P<0.05, ‡‡P<0.01, vehicle vs. exendin-4
Fig. 5 Impaired effects of
nutrients on S6K1 activation in
VMH and LH from Pask−/−mice.
Immunoblot analysis of phospho-
S6K1 (Thr389) (P-S6K1) and
total S6K1 (S6K1). The blots
were reprobed for β-actin as a
loading control. Bar graphs
represent means ± SEM; n=3–4
of the densitometric values,
expressed as the ratio with respect
to β-actin and non-
phosphorylated forms.
Representative western blots of
the graphs are also shown. The
values were normalized by fasted
WT untreated mice. *P<0.05,
fasted vs. re-feed; #P<0.05,
##P<0.01, WT vs. Pask−/−;
‡P<0.05, vehicle vs. exendin-4
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PASK-Deficient Mouse Liver Has an Altered AMPK
Response to Fasting/Re-feeding States
The activation/inactivation state of AMPK and S6K1 under
fasting/re-feeding conditions was also checked in the liver to
test the response of metabolic sensors in PASK-deficient mice
in peripheral tissues. Our data showed no differences on
AMPKα2 and S6K1 protein expression under the conditions
analysed in both PASK-deficient and wild-type mice
(Fig. 6a, b). The activation of AMPK decreased after re-
feeding, and exendin-4 treatment reversed this effect in wild-
type mice (Fig. 6a). In contrast, AMPK activity was enhanced
after re-feeding in PASK-deficient mice (Fig. 6a). The maxi-
mal activation of S6K1 was observed after re-feeding, and the
presence of exendin-4 reversed the effect in wild-type and
PASK-deficient mice (Fig. 6b). Nevertheless, the S6K1 acti-
vation level was higher in PASK-deficient mice (Fig. 6b).
PASK-Deficient Mice Display Altered Feeding and Blood
Glucose Levels in Response to Subcutaneous Exendin-4
Treatment
To check whether PASK is required for the exendin-4 anorex-
igenic effect on food intake, we tested the feeding response
after subcutaneous administration of exendin-4 (250 ng/100 g
body weight) in PASK-deficient mice. We have previously
reported an anorexigenic effect of exendin-4 in lean and obese
rats [24] and also suggested that this effect can be explained
by the regulatory effect exendin-4 has on hypothalamic
AMPK and S6K1 activities [25]. Food intake was similar in
wild-type and PASK-deficient mice (Fig. 7a). The treatment
with exendin-4 decreased food intake by more than 75% after
1 to 2 h of re-feeding in control wild-type mice (Fig. 7a).
However, the treatment with exendin-4 reduced food intake to
45 % in PASK-deficient mice (Fig. 7a). The exendin-4 treat-
ment was more potent for inhibiting food intake in wild-type
than in PASK-deficient mice, but only after 60 min of re-
feeding (Fig. 7a).
Blood glucose levels were measured in Pask−/−mice fasted
(24 and 48 h) and after re-feeding for 3 h in the absence or
presence of exendin-4 (Fig. 7b). Glucose levels rise signifi-
cantly after 3 h of re-feeding in both wild-type and Pask−/−
mice, compared to fasted animals, although glucose circulat-
ing levels in fasted and re-fed animals were similar in both
types of mice. Treatment with exendin-4 for 1 h significantly
decreased the glucose levels in fasted and re-fed conditions.
After re-feeding, the presence of exendin-4 decreased blood
glucose levels by ~64 and ~42 % in wild-type and Pask−/−
mice, respectively.
Serum insulin levels were similar in Pask−/− mice com-
pared to wild-type controls in fasted and re-fed conditions
(Table 2). The administration of exendin-4 for 1 h in fasted
mice increased insulin levels in both wild-type and Pask−/−
mice. By contrast, treatment with exendin-4 for 1 h in re-fed
Fig. 6 Impaired effects of
nutrients on AMPK activity in
liver from Pask−/−mice. a
Immunoblot analysis of phospho-
AMPK (Thr172) (P-AMPK) and
total AMPK (AMPK). b
Immunoblot analysis of phospho-
S6K1 (Thr389) (P-S6K1) and
total S6K1 (S6K1). The blots
were reprobed for β-actin to
normalize the results. Bar graphs
represent means ± SEM; n=3–4
of the densitometric values,
expressed as the ratio with respect
to β-actin and non-
phosphorylated forms.
Representative western blots of
the graphs are also shown. The
values were normalized by fasted
WT untreated mice. **P<0.01,
***P<0.001, fasted vs. re-feed;
#P<0.05, ##P<0.01, ###P<0.001,
WT vs. Pask−/−; ‡P<0.05,
‡‡‡P<0.001, vehicle vs. exendin-4
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mice decreased serum insulin levels, and no significant differ-
ences were found between Pask−/− and wild-type mice. There
is a concordance between the lower decrease of blood glucose
levels after exendin-4 treatment in re-fed state, with the loss of
anorexigenic power of exendin-4 in Pask−/− mice. However,
no changes were observed in the incretin effect of this peptide
in these mice with respect to wild-type ones.
Discussion
In this paper, we describe a role for PASK as a nutrient and
hormonal sensor in hypothalamic areas involved in feeding
behaviour with a different regulatory profile between VMH
and LH. Pask−/− mice also have an impaired response of
AMPK and mTOR/S6K1 pathways to fasting/re-feeding con-
ditions in VMH, LH areas and the liver. Additionally, we
focused our interest on the potential role of PASK as a medi-
ator of GLP-1/exendin-4 effects.
Previous reports analysing PASK expression in response to
glucose in pancreatic beta cells are contradictory. In MIN-6
cells, PASK expression is activated by the presence of high
glucose concentrations and it is necessary for the transcription
of the insulin gene mediated by glucose [30]. However, an
analysis of pancreatic beta cells frommice in which the kinase
domain has been removed (PASK knockout) showed that
Pask mRNA expression did not respond to elevated glucose
concentrations, and no differences in glucose-stimulated insu-
lin production were found between both types of mice [31].
Later studies indicated that PASK-deficient mice are resistant
to diet-induced obesity, with this effect being related to an
increase in the metabolic rate in skeletal muscle, although
there was no effect on the function of other metabolic sensors
(AMPK, mTOR) [7].
However, Pask expression is not only restricted to periph-
eral tissues, as it is also expressed in the central nervous
system, in hypothalamic areas involved in the control of food
intake [23]. Our results obtained by X-gal staining indicate
that PASK was located in several hypothalamic nuclei in-
volved in the control of food intake such as VMH, PVN,
ARC and lesser extended in LH. Nonetheless, the role of
PASK acting on the central nervous system and the
Fig. 7 Impaired effect of exendin-4 treatment in food intake and glucose
circulating levels in PASK-deficient mice. a Effect of the subcutaneous
administration of exendin-4 on food intake in fasted animals. Values are
means ± SEM cumulative food intake during three consecutive intervals
for six to eight determinations per group. *P<0.05, **P<0.01, re-feed
30 min vs. re-feed 60 and 120 min; #P<0.05, WT vs. Pask−/−; ‡P<0.05,
‡‡‡P<0.001, vehicle vs. exendin-4. b Plasma glucose levels were mea-
sured in fasted mice (24 and 48 h) and after re-feeding for 3 h in the
absence or presence of exendin-4 treatment for 1 h. #P<0.05, WT vs.
Pask−/−; ‡P<0.05, ‡‡‡P<0.001, vehicle vs. exendin-4.The determinations
were made in eight animals per group
Table 2 Blood insulin concentrations in mice injected sc with exendin-4 in fasted or re-feeding conditions
Feeding status Time of exendin (10 nM) treatment (h) Insulin concentrations (ng/ml)
WT Pask−/−
Basal – 0.37±0.02 (n=3) 0.40±0.02 (n=3)
Fasted 48 h – 0.22±0.05 (n=13) 0.19±0.06 (n=10)
Exendin-4 (1 h) 0.77±0.32 (n=6)‡ 1.01±0.41 (n=5)‡‡
Re-feeded 3 h – 4.13±0.83 (n=10)*** 6.10±0.99 (n=12)***
Exendin-4 (1 h) 1.37±0.52 (n=8)‡ 0.94±0.20 (n=5)‡‡
Male C57Bl/6 wild-type (WT) and PASK-deficient mice (Pask−/− ) were fasted for 48 h and then re-feeding for 3 h. Basal indicates mice housed in
standard conditions, fed ad libitum, with no previous fasting period. Exendin-4 (250 ng/100 g body weight, Bachem) in saline or the saline vehicle alone
(−) was subcutaneously (sc) injected during the last 1 h
*P<0.05; ***P<0.001 (fasted vs. re-feeded); ‡P<0.05; ‡‡P<0.01 (exendine-4 treatment vs. no exendine-4 treatment)
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interrelationship with other metabolic brain sensors still re-
main poorly understood. The important role hypothalamic
metabolic sensors play in controlling food intake and main-
taining the energy balance throughout the body has been
extensively studied in recent years. At least two kinds of
glucose sensor neurons have been described in the brain:
glucose-excited neurons are located mainly in the VMH and
are excited by increased glucose levels in the extracellular
space, while glucose-inhibited neurons (mainly present in the
LH) are excited by decreases in glucose concentrations [32].
These two areas play different roles in the control of food
intake and were defined as centres of satiety and hunger,
respectively. Hypothalamic AMPK and mTOR/S6K1 path-
ways respond to changes in glucose and other nutrients in
opposite ways, and their effects on the regulation of food
intake can overlap. We have also recently reported that the
antidiabetogenic and anorexigenic agent exendin-4 counter-
acts the activation/inactivation of AMPK and mTOR/S6K
pathways in hypothalamic areas involved in feeding behav-
iour, such as VMH and LH, helping to balance the proper
activation of these metabolic sensors in lean and obese rats
[25].
Pask mRNA levels in LH were upregulated after re-
feeding. However, we observed an elevated expression of
truncated PASK mRNA levels in both VMH and LH in
PASK-deficient mice and a lack of regulation under fasting
or re-feeding conditions. We have previously reported that the
Pask gene was regulated by glucose and the anorexigenic
peptide GLP-1, which is released from intestinal L-cells in
the presence of nutrient abundance and exerts a dual role as an
incretin and anorexigenic peptide reporting the nutrient status
to the brain. Thus, a high glucose concentration decreased
Pask mRNA expression in VMH and LH from rat hypotha-
lamic organotypic cultures. However, GLP-1 treatment at
elevated glucose concentrations increased Pask mRNA in
LH [23]. The effect of high glucose and GLP-1 in LH is
consistent with the results found in vivo, taking into account
that the re-feeding state must be characterized by both elevat-
ed glucose and GLP-1 levels released after eating.
Another interesting finding is that PASK deficiency alters
the nutrient response of AMPK and mTOR/S6K1 pathways in
hypothalamic areas involved in feeding behaviour. Our data
show the activation of hypothalamic AMPK in fasted state
compared to re-feeding conditions, with the opposite effect in
the activation level of S6K1 in LH in wild-type mice. Similar
data were observed in VMH, although the differences were
not significant. These data are consistent with the results
previously described in rodents [21, 25, 33, 34]. However,
exendin-4 treatment in fasted animals induced the activation
of both metabolic sensors AMPK and S6K1 in a similar way
to the re-feed condition, although exendin-4 treatment de-
creased blood glucose levels. These data suggest that the
exendin-4 effect prevails over the glucose regulatory effect.
In contrast, the treatment with exendin-4 in re-feeding condi-
tions decreased glucose circulating levels, and the activation
of S6K1 also decreased significantly, althoughAMPK activity
remained low. Although previous results indicated that there is
no relationship between PASK deficiency and the activity of
other metabolic sensors in the liver or muscle under the
conditions studied [7], we observed that PASK deficiency
impaired AMPK and S6K1 response to both the nutritional
state and exendin-4 treatment in hypothalamic areas. In this
way, AMPK and S6K1 showed an elevated activation state in
fasted and re-fed conditions, respectively, in both LH and
VMH. Additionally, in this study, we observed that the regu-
latory effect of exendin-4 in both AMPK and S6K1was lost in
PASK-deficient mice. A similar effect was observed in PASK
knockdown neuroblastoma cells, suggesting that PASK is
implicated in some GLP-1 actions [23]. We also observed that
AMPK response to nutrients was altered in peripheral tissues
as the liver in PASK-deficient mice. In fasted animals, the
activation was similar to wild-type mice in accordance with
the data reported by Hao et al. [7]. Nevertheless, the activation
level of AMPK increased after re-feeding, and activation of
S6K1 was also higher than in control mice. Then, AMPK and
mTOR were both activated simultaneously after re-feeding
while GSK3β was inhibited in the liver from PASK-deficient
mice (data not shown). It is accepted that the activation of
AMPK in the liver and muscle can cause a decrease in blood
glucose and lipid levels [35]. The elevated AMPK activity
may also explain the increased glucose and lipid oxidation
previously reported [7].
We have also confirmed here that the anorexigenic effect of
exendin-4 was partially inhibited and yet still observed in
PASK-deficient mice. The anorexigenic effect of exendin-4
was reduced in PASK-deficient mice. This finding is also in
accordance with the significantly higher blood glucose levels
found after exendin-4 treatment in PASK-deficient mice.
Thus, PASK-deficient mice record a higher blood glucose
concentration and similar insulin levels after exendin-4 ad-
ministration during the last hour. However, glucose and insu-
lin circulating levels in fasted and re-fed conditions were not
significantly altered in PASK-deficient mice, confirming pre-
vious results of food intake and those obtained with a glucose
tolerance test [7]. Nevertheless, our data suggest that some of
the exendin-4 effects are mediated through AMPK,
mTOR/S6K1 and PASK pathways that are impaired, but other
hypothalamic signalling pathways are still active in PASK-
deficient mice.
The activation of mTOR in the hypothalamus has been
related to anorexia [22, 34, 36, 37]. However, mice with a
TSC1 defic iency in the hypothalamus and pro-
opiomelanocortin (POMC) neurons, which promotes mTOR
activation, develop an orexigenic response [38]. It has also
been reported that the orexigenic effect of ghrelin, one of the
intestinal peptides, is mediated by the hypothalamic mTOR
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pathway [39]. Ghrelin also activates the AMPK and stimulates
food intake [40, 41]. Both AMPK and mTOR/S6K1 pathways
have opposite cellular effects for regulating metabolism and cell
growth, for example. Thus, AMPK and mTOR respond to
changes in glucose and other nutrients in opposite ways, and
their effects on the regulation of food intake may overlap. Along
these lines, previous data have reported interrelations between
both routes. The activation of AMPK induces the inhibition of
mTOR activity and also that of S6K1 phosphorylates while
inhibiting the activity of AMPKα2 in the hypothalamus [20].
AMPK and mTOR in PASK-deficient mice are both activated
simultaneously in the areas involved in the control of food intake,
suggesting that the PASK function could be critical for maintain-
ing both the regulation of the on/off activation of both pathways
and the regulatory role of exendin-4 in food intake. Inoki et al.
reported that inhibition ofmTORbyAMPKactivation required a
coordinated phosphorylation of TSC2 by AMPK and GSK3β
[42]. In accordance, we observed that GSK3β was more
inhibited after re-feeding in liver fromPASK-deficientmice (data
not shown). These results would suggest one possible explana-
tion for the lack of coordination between AMPK activation and
mTOR/S6K1 inhibition in PASK-deficient mice although sub-
sequent studies will be needed to clarify this hypothesis. The
deregulation of these signalling pathways might be involved in
the development of obesity and type 2 diabetes. A mutation in
the PASK gene has been described in the early onset of diabetes,
which modulates glucose-stimulated insulin secretion [43]. A
decrease in PASK expression was also found in pancreatic islets
from human with type 2 diabetes [8]. These data seem to
contradict the resistance to the development of obesity previously
described in PASK-deficient mice [7].
The importance of PASK and its relationship with diseases
such as obesity and type 2 diabetesmay also depend on its ability
to regulate AMPK and mTOR/S6K1 activities, as altered re-
sponses of AMPK could also be involved in obesity and type 2
diabetes [44]. Several examples have been reported: the use of
AMPK-knockout mice deficient in the catalytic subunit has
shown that while AMPKα1−/− mice have no metabolic alter-
ations, AMPKα2−/−mice are insulin-resistant, with no apparent
changes in body weight or food intake [45–47]. Specific dele-
tions of AMPKα2 in hypothalamic POMC neurons or in hypo-
thalamic agouti-related peptide (AgRP) neurons modified the
feeding behaviour and the maintenance of energy and body
weight homeostasis. Thus, the AMPKα2 KO in POMC neurons
developed obesity and lower energy expenditure [48]. By con-
trast, mice with an AMPKα2 deficiency in AgRP neurons
developed an age-dependent lean phenotype [48]. Furthermore,
it has also been reported that AMPKβ1-knockout mice had a
lower food intake and reduced total body weight [49]. Neuronal
protein tyrosine phosphatase 1B-deficient mice are resistant to
diet-induced obesity, showing lower hypothalamic AMPK acti-
vation and higher energy expenditure [50]. S6K1-deficient mice
are also resistant to diet-induced obesity [51]. In contrast,
regarding PASK-deficient mice that are also resistant to diet-
induced obesity, we observed that mTOR/S6K1 pathway is
highly activated in the hypothalamus, and the AMPK is also
activated, which furthermore contradicts the data reported on
PASK knockdown by siRNA in cultured myoblasts that are
posited to cause increased glucose and palmitate oxidation and
elevated cellular ATP levels [7]. It also contradicts our data on
PASK knockdown neuroblastoma cells in which we observed
increased ATP levels and the loss of AMPK activation at low
glucose levels [23].
The interpretation of the phenotypes in knockout mice is
difficult due the redundancy of regulatory mechanisms. Several
hypothalamic sensors detect nutrient levels, which could com-
pensate and interrelate with each other, as well as the presence of
many anorexigenic peptides that control their activation and
inactivation in order to regulate feeding behaviour and energy
homeostasis and maintain body weight. However, in vitro stud-
ies, where the compensatory mechanisms are limited, have re-
vealed that PASKplays as a nutrient sensor in neuroblastoma and
hypothalamic cells [23]. We also show here how PASK is
involved in the control of the gene expression of several genes,
such as Ampkα2 and Hipk2 and its role as a mediator of the
effects of exendin-4 on the regulation of genes coding to LKB1,
TSC2, AKT1, mTOR, eEF1-α1 and nNOS1. The effects of
PASK deficiency were different in VMH and LH. These hypo-
thalamic areas contain different distributions of neuron glucose
responsive (GE) or glucose inhibited (GI) predominant in VMH
and LH, respectively. These differences can also explain changes
in the expression of PASK that was higher in VMH than that in
LH. For this reason, we cannot rule out that PAKS deficiency
may have different effects or may be compensated differently in
both areas. In short, our results show that PASK is a nutrient
sensor in hypothalamic areas involved in feeding behaviour, and
the PASK function is decisive for maintaining the nutrient effect
on hypothalamic AMPK and mTOR/S6K1 pathways. Further-
more, PASK is required for the correct signalling of GLP-1/
exendin-4.
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On line resource 1. Identification of probes used in the different gene expression assays 
 
MULTIPLE TAQMAN® GENE EXPRESSION ASSAY 
Gene 
Symbol  Gen Identification Mouse probe identification (Taq Man®Assay) Protein name 
Rn 18s 19791 Hs99999901_s1 18S 
Actb 11461 Hs99999903_m1 β-ACTIN 
Pask 269224 Mm00435916_m1 PASK 
Prkar2a 19087 Mm00435916_m1 PKA RIIα 
Rps6kb1 72508 Mm01310033_m1 S6K1 
Mtor 56717 Mm00444968_m1 mTOR 
Eif4b 75705 Mm00778003_s1 eIF-4B 
Rps6 20104 Mm02342456_g1 S6 
Eef2k 13631 Mm00432996_m1 eEF-2K/CaMK 
Eef1a1 13627 Mm01973893_m1 eEF1-α1 
Stk11 20869 Mm00488470_m1 LKB1 
Pdk1 228026 Mm00499855_m1 PDK1 
Tsc2 22084 Mm00442004_m1 TSC2 
Akt1 11651 Mm01331624_m1 AKT1 
nNos1 18125 Mm00435175_m1 nNOS 
Hipk2 15258 Mm00439329_m1 HIPK2 
Gapdh 14433 Mm99999915_g1 GAPDH 
REAL-TIME POLYMERASE CHAIN REACTION (TAQMAN® ASSAY) 
Gene Symbol Primers (Forward and reverse) Taqman probe Protein name 
Rat Prkaa2  5´-GTGGATCGCCAAATTA 
TGCA-3´ 
5´-GGGAGGGTGCCACA 
GAGAA-3´ 
6-FAM-TAC AGC CTT CTT GAC ATG A-MGB AMPKα2 
Mouse Prkaa2  Mm 01264789_m1 AMPKα2 
Rat Pask  5´-TGGACTGCAGTGGAGAA 
GGGA-3´ 
5´-ATCCTCTAAAACCTTCT 
CCTTCTTA 
ATAAA-3´   
6-FAM-ACA AAG AGA TGG TGG TGA A-MGB PASK 
POLYMERASE CHAIN REACTION 
Mouse Glp-1r   Mm 00445292_m1 GLP-1R 
Mouse-Rat Sf-1 5´ –AGCTGCTGGTGTTGGACCA-3´ 
5´-TCCAGTAACCAGCAGGATGCT-3´  
SF-1 
Mouse Prepro-orexin 5´ –CTCAGACTCCTTGGGT 
ATTT-3´ 
5´-CAATCCGGAGAGAGA 
TGGT -3´ 
 PREPRO-
OREXIN 
 

